The specialty chemicals firm reported adjusted earnings above forecasts and revenue growth of $21.05M over expectations.
Innospec posted non-GAAP earnings per share of $1.05, exceeding estimates by $0.04. Revenue reached $453.2M, surpassing projections by $21.05M.
Analysts had anticipated earnings of $1.01 per share and revenue of $432.15M for the quarter. The company’s performance reflects stronger demand in its core markets.
Shares showed modest movement in after-hours trading as investors digested the results.